Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Enc, FY; Imeryuz, N; Akin, L; Turoglu, T; Dede, F; Haklar, G; Tekesin, N; Bekiroglu, N; Yegen, BC; Rehfeld, JF; Holst, JJ; Ulusoy, NB
   Inhibition of gastric emptying by acarbose is correlated with GLP-1 response and accompanied by CCK release
   AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
   
   F.Y. Enc et al., "Inhibition of gastric emptying by acarbose is correlated with GLP-1 response and accompanied by CCK release", AM J P-GAST, 281(3), 2001, pp. G752-G763
2. Mertes, G
   Safety and efficacy of acarbose in the treatment of Type 2 diabetes: data from a 5-year surveillance study
   DIABETES RESEARCH AND CLINICAL PRACTICE
   
   G. Mertes, "Safety and efficacy of acarbose in the treatment of Type 2 diabetes: data from a 5-year surveillance study", DIABET RE C, 52(3), 2001, pp. 193-204
3. Standl, E; Schernthaner, G; Rybka, J; Hanefeld, M; Raptis, SA; Naditch, L
   Improved glycaemic control with miglitol in inadequately-controlled type 2diabetics
   DIABETES RESEARCH AND CLINICAL PRACTICE
   
   E. Standl et al., "Improved glycaemic control with miglitol in inadequately-controlled type 2diabetics", DIABET RE C, 51(3), 2001, pp. 205-213
4. Chiasson, JL; Naditch, L
   The synergistic effect of miglitol plus metformin combination therapy in the treatment of type 2 diabetes
   DIABETES CARE
   
   J.L. Chiasson e L. Naditch, "The synergistic effect of miglitol plus metformin combination therapy in the treatment of type 2 diabetes", DIABET CARE, 24(6), 2001, pp. 989-994
5. Yang, YS; Danis, RP; Peterson, RG; Dolan, PL; Wu, YQ
   Acarbose partially inhibits microvascular retinopathy in the Zucker diabetic fatty rat (ZDF/Gmi(TM)-(fa)under-bar)
   JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS
   
   Y.S. Yang et al., "Acarbose partially inhibits microvascular retinopathy in the Zucker diabetic fatty rat (ZDF/Gmi(TM)-(fa)under-bar)", J OCUL PH T, 16(5), 2000, pp. 471-479
6. Fukumori, Y; Maeda, N; Takeda, H; Onodera, S; Shiomi, N
   Serum glucose and insulin response in rats administered with sucrose or starch containing adenosine, inosine or cytosine
   BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY
   
   Y. Fukumori et al., "Serum glucose and insulin response in rats administered with sucrose or starch containing adenosine, inosine or cytosine", BIOS BIOT B, 64(2), 2000, pp. 237-243
7. Juntti-Berggren, L; Pigon, J; Hellstrom, P; Holst, JJ; Efendic, S
   Influence of acarbose on post-prandial insulin requirements in patients with Type 1 diabetes
   DIABETES NUTRITION & METABOLISM
   
   L. Juntti-Berggren et al., "Influence of acarbose on post-prandial insulin requirements in patients with Type 1 diabetes", DIABET NUTR, 13(1), 2000, pp. 7-12
8. Meneilly, GS; Ryan, EA; Radziuk, J; Lau, DCW; Yale, JF; Morais, J; Chiasson, JL; Rabasa-Lhoret, R; Maheux, P; Tessier, D; Wolever, T; Josse, RG; Elahi, D
   Effect of acarbose on insulin sensitivity in elderly patients with diabetes
   DIABETES CARE
   
   G.S. Meneilly et al., "Effect of acarbose on insulin sensitivity in elderly patients with diabetes", DIABET CARE, 23(8), 2000, pp. 1162-1167
9. Chehade, JM; Mooradian, AD
   A rational approach to drug therapy of type 2 diabetes mellitus
   DRUGS
   
   J.M. Chehade e A.D. Mooradian, "A rational approach to drug therapy of type 2 diabetes mellitus", DRUGS, 60(1), 2000, pp. 95-113
10. Mooradian, AD; Albert, SG; Wittry, S; Chehade, J; Kim, J; Bellrichard, B
    Dose-response profile of acarbose in older subjects with type 2 diabetes
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES
    
    A.D. Mooradian et al., "Dose-response profile of acarbose in older subjects with type 2 diabetes", AM J MED SC, 319(5), 2000, pp. 334-337
11. Bartsocas, CS
    The Greek contribution to diabetes research
    DIABETES-METABOLISM RESEARCH AND REVIEWS
    
    C.S. Bartsocas, "The Greek contribution to diabetes research", DIABET M R, 15(5), 1999, pp. 362-372
12. Matsui, T; Oki, T; Osajima, Y
    Isolation and identification of peptidic alpha-glucosidase inhibitors derived from sardine muscle hydrolyzate
    ZEITSCHRIFT FUR NATURFORSCHUNG C-A JOURNAL OF BIOSCIENCES
    
    T. Matsui et al., "Isolation and identification of peptidic alpha-glucosidase inhibitors derived from sardine muscle hydrolyzate", Z NATURFO C, 54(3-4), 1999, pp. 259-263
13. Emilien, G; Maloteaux, JM; Ponchon, M
    Pharmacological management of diabetes: Recent progress and future perspective in daily drug treatment
    PHARMACOLOGY & THERAPEUTICS
    
    G. Emilien et al., "Pharmacological management of diabetes: Recent progress and future perspective in daily drug treatment", PHARM THERA, 81(1), 1999, pp. 37-51
14. Mooradian, AD; Thurman, JE
    Drug therapy of postprandial hyperglycaemia
    DRUGS
    
    A.D. Mooradian e J.E. Thurman, "Drug therapy of postprandial hyperglycaemia", DRUGS, 57(1), 1999, pp. 19-29
15. Minatoguchi, S; Arai, M; Uno, Y; Kariya, T; Nishida, Y; Hashimoto, K; Kawasaki, M; Takemura, G; Fujiwara, T; Fujiwara, H
    A novel anti-diabetic drug, miglitol, markedly reduces myocardial infarct size in rabbits
    BRITISH JOURNAL OF PHARMACOLOGY
    
    S. Minatoguchi et al., "A novel anti-diabetic drug, miglitol, markedly reduces myocardial infarct size in rabbits", BR J PHARM, 128(8), 1999, pp. 1667-1672
16. SEIFARTH C; BERGMANN J; HOLST JJ; RITZEL R; SCHMIEGEL W; NAUCK MA
    PROLONGED AND ENHANCED SECRETION OF GLUCAGON-LIKE PEPTIDE-1 (7-36 AMIDE) AFTER ORAL SUCROSE DUE TO ALPHA-GLUCOSIDASE INHIBITION (ACARBOSE) IN TYPE-2 DIABETIC-PATIENTS
    Diabetic medicine
    
    C. Seifarth et al., "PROLONGED AND ENHANCED SECRETION OF GLUCAGON-LIKE PEPTIDE-1 (7-36 AMIDE) AFTER ORAL SUCROSE DUE TO ALPHA-GLUCOSIDASE INHIBITION (ACARBOSE) IN TYPE-2 DIABETIC-PATIENTS", Diabetic medicine, 15(6), 1998, pp. 485-491
17. TORMO MA; ROPERO MF; NIETO M; MARTINEZ IM; CAMPILLO JE
    EFFECT OF MIGLITOL ADMINISTRATION TO NON-INSULIN-DEPENDENT DIABETIC RATS
    General pharmacology
    
    M.A. Tormo et al., "EFFECT OF MIGLITOL ADMINISTRATION TO NON-INSULIN-DEPENDENT DIABETIC RATS", General pharmacology, 30(1), 1998, pp. 125-129
18. NAUCK MA; HOLST JJ; WILLMS B; SCHMIEGEL W
    GLUCAGON-LIKE PEPTIDE-1 (GLP-1) AS A NEW THERAPEUTIC APPROACH FOR TYPE-2-DIABETES
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
    
    M.A. Nauck et al., "GLUCAGON-LIKE PEPTIDE-1 (GLP-1) AS A NEW THERAPEUTIC APPROACH FOR TYPE-2-DIABETES", EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 105(4), 1997, pp. 187-195
19. SEGAL P; FEIG PU; SCHERNTHANER G; RATZMANN KP; RYBKA J; PETZINNA D; BERLIN C
    THE EFFICACY AND SAFETY OF MIGLITOL THERAPY COMPARED WITH GLIBENCLAMIDE IN PATIENTS WITH NIDDM INADEQUATELY CONTROLLED BY DIET ALONE
    Diabetes care
    
    P. Segal et al., "THE EFFICACY AND SAFETY OF MIGLITOL THERAPY COMPARED WITH GLIBENCLAMIDE IN PATIENTS WITH NIDDM INADEQUATELY CONTROLLED BY DIET ALONE", Diabetes care, 20(5), 1997, pp. 687-691
20. HOLLANDER P; PISUNYER X; CONIFF RF
    ACARBOSE IN THE TREATMENT OF TYPE-I DIABETES
    Diabetes care
    
    P. Hollander et al., "ACARBOSE IN THE TREATMENT OF TYPE-I DIABETES", Diabetes care, 20(3), 1997, pp. 248-253
21. CONIFF R; KROL A
    ACARBOSE - A REVIEW OF US CLINICAL-EXPERIENCE
    Clinical therapeutics
    
    R. Coniff e A. Krol, "ACARBOSE - A REVIEW OF US CLINICAL-EXPERIENCE", Clinical therapeutics, 19(1), 1997, pp. 16-26
22. ASANO N; KATO A; KIZU H; MATSUI K; GRIFFITHS RC; JONES MG; WATSON AA; NASH RJ
    ENZYMATIC-SYNTHESIS OF THE GLYCOSIDES OF CALYSTEGINES B-1 AND B-2 ANDTHEIR GLYCOSIDASE INHIBITORY ACTIVITIES
    Carbohydrate research
    
    N. Asano et al., "ENZYMATIC-SYNTHESIS OF THE GLYCOSIDES OF CALYSTEGINES B-1 AND B-2 ANDTHEIR GLYCOSIDASE INHIBITORY ACTIVITIES", Carbohydrate research, 304(2), 1997, pp. 173-178
23. BRESSLER R; JOHNSON DG
    ORAL ANTIDIABETIC DRUG-USE IN THE ELDERLY
    Drugs & aging
    
    R. Bressler e D.G. Johnson, "ORAL ANTIDIABETIC DRUG-USE IN THE ELDERLY", Drugs & aging, 9(6), 1996, pp. 418-437
24. CAMPBELL LK; WHITE JR; CAMPBELL RK
    ACARBOSE - ITS ROLE IN THE TREATMENT OF DIABETES-MELLITUS
    The Annals of pharmacotherapy
    
    L.K. Campbell et al., "ACARBOSE - ITS ROLE IN THE TREATMENT OF DIABETES-MELLITUS", The Annals of pharmacotherapy, 30(11), 1996, pp. 1255-1262
25. MATSUI T; YOSHIMOTO C; OSAJIMA K; OKI T; OSAJIMA Y
    IN-VITRO SURVEY OF ALPHA-GLUCOSIDASE INHIBITORY FOOD COMPONENTS
    Bioscience, biotechnology, and biochemistry
    
    T. Matsui et al., "IN-VITRO SURVEY OF ALPHA-GLUCOSIDASE INHIBITORY FOOD COMPONENTS", Bioscience, biotechnology, and biochemistry, 60(12), 1996, pp. 2019-2022
26. SERRANO JS; JIMENEZ CM; SERRANO MI; BALBOA B
    A POSSIBLE INTERACTION OF POTENTIAL CLINICAL INTEREST BETWEEN DIGOXINAND ACARBOSE
    Clinical pharmacology and therapeutics
    
    J.S. Serrano et al., "A POSSIBLE INTERACTION OF POTENTIAL CLINICAL INTEREST BETWEEN DIGOXINAND ACARBOSE", Clinical pharmacology and therapeutics, 60(5), 1996, pp. 589-592
27. TORMO MA; ROPERO MF; NIETO M; MARTINEZ IM; CAMPILLO JE
    IN-VITRO STUDY OF THE EFFECT OF MIGLITOL ON CARBOHYDRATE DIGESTION AND INTESTINAL METABOLISM IN NORMAL AND NON-INSULIN-DEPENDENT DIABETIC RATS
    Canadian journal of physiology and pharmacology
    
    M.A. Tormo et al., "IN-VITRO STUDY OF THE EFFECT OF MIGLITOL ON CARBOHYDRATE DIGESTION AND INTESTINAL METABOLISM IN NORMAL AND NON-INSULIN-DEPENDENT DIABETIC RATS", Canadian journal of physiology and pharmacology, 74(11), 1996, pp. 1196-1203
28. SILVA CP; TERRA WR
    AN ALPHA-GLUCOSIDASE FROM PERIMICROVILLAR MEMBRANES OF DYSDERCUS-PERUVIANUS (HEMIPTERA, PYRRHOCORIDAE) MIDGUT CELLS - PURIFICATION AND PROPERTIES
    Insect biochemistry and molecular biology
    
    C.P. Silva e W.R. Terra, "AN ALPHA-GLUCOSIDASE FROM PERIMICROVILLAR MEMBRANES OF DYSDERCUS-PERUVIANUS (HEMIPTERA, PYRRHOCORIDAE) MIDGUT CELLS - PURIFICATION AND PROPERTIES", Insect biochemistry and molecular biology, 25(4), 1995, pp. 487-494
29. STURMER W; EBERT E; CHRISTL SU; KASPER H
    INFLUENCE OF ACARBOSE-INDUCED STARCH MALABSORPTION ON THE GENERATION OF INTERMEDIATES BY COLONIC FERMENTATION IN HEALTHY-SUBJECTS
    Diabetes, nutrition & metabolism
    
    W. Sturmer et al., "INFLUENCE OF ACARBOSE-INDUCED STARCH MALABSORPTION ON THE GENERATION OF INTERMEDIATES BY COLONIC FERMENTATION IN HEALTHY-SUBJECTS", Diabetes, nutrition & metabolism, 8(2), 1995, pp. 88-94
30. COHEN MP; VASSELLI JR; NEUMAN RG; WITT J
    TREATMENT WITH ACARBOSE, AN ALPHA-GLUCOSIDASE INHIBITOR, REDUCES INCREASED ALBUMIN EXCRETION IN STREPTOZOTOCIN-DIABETIC RATS
    General pharmacology
    
    M.P. Cohen et al., "TREATMENT WITH ACARBOSE, AN ALPHA-GLUCOSIDASE INHIBITOR, REDUCES INCREASED ALBUMIN EXCRETION IN STREPTOZOTOCIN-DIABETIC RATS", General pharmacology, 26(6), 1995, pp. 1355-1361
31. BISCHOFF H
    THE MECHANISM OF ALPHA-GLUCOSIDASE INHIBITION IN THE MANAGEMENT OF DIABETES
    Clinical and investigative medicine
    
    H. Bischoff, "THE MECHANISM OF ALPHA-GLUCOSIDASE INHIBITION IN THE MANAGEMENT OF DIABETES", Clinical and investigative medicine, 18(4), 1995, pp. 303-311
32. QUALMANN C; NAUCK MA; HOLST JJ; ORSKOV C; CREUTZFELDT W
    GLUCAGON-LIKE PEPTIDE-1 (7-36-AMIDE) SECRETION IN RESPONSE TO LUMINALSUCROSE FROM THE UPPER AND LOWER GUT - A STUDY USING ALPHA-GLUCOSIDASE INHIBITION (ACARBOSE)
    Scandinavian journal of gastroenterology
    
    C. Qualmann et al., "GLUCAGON-LIKE PEPTIDE-1 (7-36-AMIDE) SECRETION IN RESPONSE TO LUMINALSUCROSE FROM THE UPPER AND LOWER GUT - A STUDY USING ALPHA-GLUCOSIDASE INHIBITION (ACARBOSE)", Scandinavian journal of gastroenterology, 30(9), 1995, pp. 892-896
33. GOKE B; FUDER H; WIECKHORST G; THEISS U; STRIDDE E; LITTKE T; KLEIST P; ARNOLD R; LUCKER PW
    VOGLIBOSE (AO-128) IS AN EFFICIENT ALPHA-GLUCOSIDASE INHIBITOR AND MOBILIZES THE ENDOGENOUS GLP-1 RESERVE
    Digestion
    
    B. Goke et al., "VOGLIBOSE (AO-128) IS AN EFFICIENT ALPHA-GLUCOSIDASE INHIBITOR AND MOBILIZES THE ENDOGENOUS GLP-1 RESERVE", Digestion, 56(6), 1995, pp. 493-501
34. ESCOBARJIMENEZ F; BARAJAS C; DELEIVA A; CANO FJ; MASOLIVER R; HERRERAPOMBO JL; HERNANDEZMIJARES A; PINON F; DELACALLE H; TEBAR J; SOLER J; COBOS A; GUARDIOLA E
    EFFICACY AND TOLERABILITY OF MIGLITOL IN THE TREATMENT OF PATIENTS WITH NON-INSULIN-DEPENDENT DIABETES-MELLITUS
    Current therapeutic research
    
    F. Escobarjimenez et al., "EFFICACY AND TOLERABILITY OF MIGLITOL IN THE TREATMENT OF PATIENTS WITH NON-INSULIN-DEPENDENT DIABETES-MELLITUS", Current therapeutic research, 56(3), 1995, pp. 258-268
35. TAN A; VANDENBROEK L; BOLSCHER J; VERMAAS DJ; PASTOORS L; VANBOECKEL C; PLOEGH H
    INTRODUCTION OF OXYGEN INTO THE ALKYL CHAIN OF N-DECYL-DNM DECREASES LIPOPHILICITY AND RESULTS IN INCREASED RETENTION OF GLUCOSE RESIDUES ON N-LINKED OLIGOSACCHARIDES
    Glycobiology
    
    A. Tan et al., "INTRODUCTION OF OXYGEN INTO THE ALKYL CHAIN OF N-DECYL-DNM DECREASES LIPOPHILICITY AND RESULTS IN INCREASED RETENTION OF GLUCOSE RESIDUES ON N-LINKED OLIGOSACCHARIDES", Glycobiology, 4(2), 1994, pp. 141-149
36. ABOTOMEY C; COWDEN WB; HILL CE
    CARBOHYDRATES PLAY A ROLE IN NEURITE OUTGROWTH IN-VIVO DURING DEVELOPMENT AND REGENERATION
    Developmental brain research
    
    C. Abotomey et al., "CARBOHYDRATES PLAY A ROLE IN NEURITE OUTGROWTH IN-VIVO DURING DEVELOPMENT AND REGENERATION", Developmental brain research, 79(1), 1994, pp. 101-114
37. RIOS MS
    ACARBOSE AND INSULIN THERAPY IN TYPE-I DIABETES-MELLITUS
    European journal of clinical investigation
    
    M.S. Rios, "ACARBOSE AND INSULIN THERAPY IN TYPE-I DIABETES-MELLITUS", European journal of clinical investigation, 24, 1994, pp. 36-39
38. LEFEBVRE PJ; SCHEEN AJ
    THE USE OF ACARBOSE IN THE PREVENTION AND TREATMENT OF HYPOGLYCEMIA
    European journal of clinical investigation
    
    P.J. Lefebvre e A.J. Scheen, "THE USE OF ACARBOSE IN THE PREVENTION AND TREATMENT OF HYPOGLYCEMIA", European journal of clinical investigation, 24, 1994, pp. 40-44
39. ESCOBARJIMENEZ F; DELEIVA A; PINON F; SOLER J; TEBAR J; SANCHO MA; HERRERAPOMBO JL; PALLARDO LF; VAZQUEZ JA; DELACALLE H; FIGUEROLA D; GIL E; GUARDIOLA E; CAMPOS MM; FERNANDEZSOTO M; GONZALEZ A; VELA MT; ARROYO A; INIGO P; LIGORRIA C; JIMENEZ A
    CLINICAL EFFICACY AND TOLERANCE OF ACARBOSE IN THE TREATMENT OF INSULIN-DEPENDENT DIABETIC-PATIENTS (TYPE-I)
    Medicina Clinica
    
    F. Escobarjimenez et al., "CLINICAL EFFICACY AND TOLERANCE OF ACARBOSE IN THE TREATMENT OF INSULIN-DEPENDENT DIABETIC-PATIENTS (TYPE-I)", Medicina Clinica, 100(13), 1993, pp. 488-491
40. KATOVICH MJ; MELDRUM MJ
    EFFECTS OF INSULIN AND ACARBOSE ALONE AND IN COMBINATION IN THE FEMALE STREPTOZOTOCIN-INDUCED DIABETIC RAT
    Journal of pharmaceutical sciences
    
    M.J. Katovich e M.J. Meldrum, "EFFECTS OF INSULIN AND ACARBOSE ALONE AND IN COMBINATION IN THE FEMALE STREPTOZOTOCIN-INDUCED DIABETIC RAT", Journal of pharmaceutical sciences, 82(12), 1993, pp. 1209-1213
41. BALFOUR JA; MCTAVISH D
    ACARBOSE - AN UPDATE OF ITS PHARMACOLOGY AND THERAPEUTIC USE IN DIABETES-MELLITUS
    Drugs
    
    J.A. Balfour e D. Mctavish, "ACARBOSE - AN UPDATE OF ITS PHARMACOLOGY AND THERAPEUTIC USE IN DIABETES-MELLITUS", Drugs, 46(6), 1993, pp. 1025-1054